SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001384101-22-000068
Filing Date
2022-05-03
Accepted
2022-05-03 16:12:08
Documents
14
Period of Report
2022-05-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K vcyt-20220503.htm   iXBRL 8-K 38029
2 EX-99.1 PRESS RELEASE 05.03-2022 vcyt-0503228xkearningsrele.htm EX-99.1 203906
6 GRAPHIC veracytelogoa10.jpg GRAPHIC 10166
  Complete submission text file 0001384101-22-000068.txt   414502

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vcyt-20220503.xsd EX-101.SCH 1921
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vcyt-20220503_lab.xml EX-101.LAB 25250
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vcyt-20220503_pre.xml EX-101.PRE 13154
8 EXTRACTED XBRL INSTANCE DOCUMENT vcyt-20220503_htm.xml XML 11959
Mailing Address 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 243-6300
VERACYTE, INC. (Filer) CIK: 0001384101 (see all company filings)

IRS No.: 205455398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36156 | Film No.: 22886973
SIC: 8071 Services-Medical Laboratories